Best Practices for Intrathecal Drug Delivery for Pain
Neuromodulation Technology at the Neural Interface2014Vol. 17(4), pp. 354–372
Citations Over TimeTop 1% of 2014 papers
Joshua P. Prager, Timothy R. Deer, Robert M. Levy, Brian M. Bruel, Eric Buchser, David Caraway, Michael J. Cousins, Marilyn S. Jacobs, Gail L. McGlothlen, Richard Rauck, Peter S. Staats, Lisa Stearns
Related Papers
- → A Comparative Study of Intrathecal 0.5% Hyperbaric Bupivacaine & Intrathecal 0.75% Isobaric Ropivacaine in Lower Abdominal Surgeries(2020)4 cited
- → Increased cerebrospinal fluid PGE2 levels after intrathecal lidocaine in rats: Response to intrathecal pretreatment with MK801 and SC76309A(2008)
- → I6. Effect of Intrathecal Ziconotide as the First Agent in Pump on Patient-Reported Outcomes(2017)
- → A COMPARATIVE STUDY OF INTRATHECAL HYPERBARIC 0.5% BUPIVACAINE VERSUS INTRATHECAL 0.5% ISOBARIC LEVOBUPIVACAINE(2016)
- → I2 Effectiveness and Safety of Intrathecal Ziconotide Use as the First Agent in Pump(2018)